Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Corhythm
AddedFeb 17, 2024
UpdatedJun 18, 2026
Corhythm

Corhythm

Public

Corhythm Inc.: Pioneering semiconductor-based heart treatments for early atrial fibrillation detection and management.

HQ
San Jose, CA, US
Founded
2007
Overview
Compare
Fundraising
Employees
Website

Corhythm Inc. engages in the development of an implantable treatment that detects early onset of atrial fibrillation and chronic heart failure.

The company offers device that uses semiconductor technology to provide pacing and defibrillation, and delivers targeted medications when an atrial fibrillation is detected. The company was incorporated in 2007 and is based in San Jose, California.

Corhythm - Similar Companies

iRhythm logo

iRhythm

irhythmtech.com

Cormedics logo

Cormedics

cormedicscorp.com

AliveCor logo

AliveCor

alivecor.com

Atriomx logo

Atriomx

CardioFocus logo

CardioFocus

cardiofocus.com

Innerpulse logo

Innerpulse

CoreMap logo

CoreMap

coremapmedical.com

Cardiac Insight logo

Cardiac Insight

RhythmScience logo

RhythmScience

HeartHero logo

HeartHero

Cardiomems logo

Cardiomems

CardioOptics logo

CardioOptics

Phoenix Cardiac logo

Phoenix Cardiac

Cormatrix Cardiovascular logo

Cormatrix Cardiovascular

cormatrix.com

Aqua Heart logo

Aqua Heart

aquahrt.com

Corhythm - Quick Facts

Who are Corhythm's competitors?

Companies similar to Corhythm include iRhythm, Cormedics, AliveCor and Atriomx.

When was Corhythm founded?

Corhythm was founded in 2007.

Where is Corhythm's headquarters located?

Corhythm's headquarters is located in San Jose, CA, US.

When was Corhythm's last funding round?

Corhythm's most recent funding round was for $1.6M (USD) in October 2010.

How much has Corhythm raised to-date?

As of Oct 18, 2010, Corhythm has raised a total of $3.8M (USD).

How many employees does Corhythm have?

Corhythm has 5 employees as of Feb 5, 2024.

Corhythm - Classification

Industry
  • Hardware
Ownership
  • Public
Technology
  • Semiconductor
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Heart Treatments
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 15 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research